Chiral Resolution, Absolute Configuration Assignment, and Genotoxicity Evaluation of Racemic 3,4-Dihydroquinazoline as a Novel Anticancer Agent

If a new drug candidate will be a mixture of enantiomers, both enantiomers should be separately studied for at least latent genotoxicity as early as possible since the thalidomide tragedy. Our group has recently reported that KCP-10043F (OZ-001) as a racemate (±)-3,4-dihydroquinazoline derivative st...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Junseong Ahn, Dohyeong Ko, Seyoung Yang, Kwang H. Moon, Jiwon Woo, Ho Yoo, Joohoon Ahn, Jeong H. Lee, Kyung S. Chung, Kyung-T. Lee, Jae Y. Lee
Formato: article
Lenguaje:EN
Publicado: Hindawi Limited 2021
Materias:
Acceso en línea:https://doaj.org/article/6cdb29ca810b425c8948cc86c2aa4421
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares